Egyszerű nézet

dc.contributor.author Munkácsy Gyöngyi
dc.contributor.author Sztupinszki Zsófia
dc.contributor.author Herman Péter
dc.contributor.author Bán Bence
dc.contributor.author Pénzváltó Zsófia
dc.contributor.author Szarvas Nóra
dc.contributor.author Győrffy Balázs
dc.date.accessioned 2017-09-12T08:07:26Z
dc.date.available 2017-09-12T08:07:26Z
dc.date.issued 2016
dc.identifier 85015248756
dc.identifier.citation pagination= Article number e366, 7 pages; journalVolume=5; journalIssueNumber=9; journalTitle=MOLECULAR THERAPY-NUCLEIC ACIDS;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/4469
dc.identifier.uri doi:10.1038/mtna.2016.66
dc.description.abstract No independent cross-validation of success rate for studies utilizing small interfering RNA (siRNA) for gene silencing has been completed before. To assess the influence of experimental parameters like cell line, transfection technique, validation method, and type of control, we have to validate these in a large set of studies. We utilized gene chip data published for siRNA experiments to assess success rate and to compare methods used in these experiments. We searched NCBI GEO for samples with whole transcriptome analysis before and after gene silencing and evaluated the efficiency for the target and off-target genes using the array-based expression data. Wilcoxon signed-rank test was used to assess silencing efficacy and Kruskal-Wallis tests and Spearman rank correlation were used to evaluate study parameters. All together 1,643 samples representing 429 experiments published in 207 studies were evaluated. The fold change (FC) of down-regulation of the target gene was above 0.7 in 18.5% and was above 0.5 in 38.7% of experiments. Silencing efficiency was lowest in MCF7 and highest in SW480 cells (FC = 0.59 and FC = 0.30, respectively, P = 9.3E-06). Studies utilizing Western blot for validation performed better than those with quantitative polymerase chain reaction (qPCR) or microarray (FC = 0.43, FC = 0.47, and FC = 0.55, respectively, P = 2.8E-04). There was no correlation between type of control, transfection method, publication year, and silencing efficiency. Although gene silencing is a robust feature successfully cross-validated in the majority of experiments, efficiency remained insufficient in a significant proportion of studies. Selection of cell line model and validation method had the highest influence on silencing proficiency.
dc.relation.ispartof urn:issn:2162-2531
dc.title Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments
dc.type Journal Article
dc.date.updated 2017-09-05T12:15:14Z
dc.language.rfc3066 en
dc.identifier.mtmt 3173397
dc.identifier.wos 000395780600001
dc.identifier.pubmed 27673562
dc.contributor.department SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika
dc.contributor.institution Semmelweis Egyetem
dc.mtmt.swordnote Munkacsy G and Sztupinszky Z contributed equally to this work.


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet